A potential breakthrough in the treatment of type 1 mediated chronic inflammatory skin diseases (ISD) has emerged, as ...

RIPK1 inhibition reduced inflammation and keratinocyte cell death in lichen planus and CLE models. Could this be a new ...

AbbVie announces US FDA approves combination treatment of Venclexta and acalabrutinib for previously untreated patients with CLL: North Chicago, Illinois Monday, February 23, 2026 ...

New research from Memorial Sloan Kettering Cancer Center (MSK) investigates harnessing the power of ferroptosis to spread cell death; reports how an ...

Researchers discover that hearing-essential proteins (TMC1/TMC2) also regulate cell membranes, and their malfunction is a primary cause of permanent hearing loss.

With cancer cases rising sharply across India, the search for more precise, less invasive and patient-friendly treatments has intensified. From robotic surgery ...

A team of researchers has clarified a biological process first observed more than 50 years ago: how tissues rebuild themselves after severe damage. The findings reveal that enzymes linked to cell ...

A multiple myeloma candidate with a new mode of action is now in Phase 2 patient trials following positive Phase 1 results showing it kills cancer ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

Researchers reveal that eosinophils suppress chordoma growth, highlighting its potential as an immunotherapeutic target ...

New study reveals how cytoplasmic and nuclear functions of USP30-AS1 converge to promote tumor growth Breast cancer progression is increasingly ...